GSK: FDA, EMA Conclude No Evidence Of Association Between Ranitidine Therapy And Cancer Development
British drug maker GSK plc (GSK,GSK.L), in its statement on Zantac (ranitidine) litigation and N-nitrosodimethylamine or NDMA, said the U.S. and European regulators have concluded there is no evidence of … Read More
